- No file added yet -
Should I have adjuvant immunotherapy? An interview study among adults with resected stage 3 melanoma and their partners.
Version 2 2021-03-26, 01:17
Version 1 2021-03-10, 18:53
media
posted on 2021-03-26, 01:17 authored by Ann Livingstone, Donna Milne, Kathy Dempsey, Danielle Muscat, Kirsten Howard, Martin Stockler, Rachael L. MortonArticle full text
The above plain language summary represents the opinions of
the authors. For a full list of declarations, including
funding and author disclosure statements, please see the full text online (see
“read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.
